Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AM Rx vs AquaVita NextGen

AM Rx
Graded #491

Lower grade

vs+6.5
AquaVita NextGen
Graded #421

Higher grade

The verdict

AquaVita NextGen takes it — 56.1/100 to 49.6/100.

AquaVita NextGen grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. AquaVita NextGen (AquaVita Wellness & Medspa) offers compounded semaglutide and tirzepatide (ODT tablets).

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAM Rx +28
50
22
Dose & formulationAquaVita NextGen +10
65
75
Clinical oversightAquaVita NextGen +41
41
82
Labs & monitoringAquaVita NextGen +4
49
53
FulfillmentAquaVita NextGen +4
58
62
Contract termsAquaVita NextGen +27
20
47
AM Rx · left barAquaVita NextGen · right bar

The numbers

MetricAM RxAquaVita NextGen
WeighScore49.6/10056.1/100
GradeCC
Scorecard rank#491#421
Semaglutide$151/mo (quarterly plan, plus a separate fee, compounded)$375/mo (first-month rate, compounded)
TirzepatideNot disclosed$320/mo (starting dose, 3-month plan, compounded)
CoverageCoverage not published5 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyYes
AM Rx

Graded #491 · C

Strengths

  • Insurance coordination for brand-name GLP-1s — as low as $25/mo
  • All four major brand-name GLP-1s available (Ozempic, Wegovy, Zepbound, Mounjaro)
  • HSA and FSA accepted
  • Video visits available with providers averaging 10+ years' experience
  • Compounded semaglutide from $151/mo on the quarterly plan

Where it loses points

  • Active FTC/DOJ lawsuit over deceptive billing and subscription practices
  • Novo Nordisk false-advertising lawsuit (Aug 2025)
  • Parent company Zealthy holds a BBB D- rating with 2,370+ complaints
  • Trustpilot 2.0/5, with 85% one-star reviews citing billing disputes and unreachable support
  • FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
AquaVita NextGen

Graded #421 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard